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We describe the epidemiological pattern and genetic 
characteristics of 242 acute dengue infections 
imported to Europe by returning travellers from 2012 
to 2014. The overall geographical pattern of imported 
dengue (South-east Asia > Americas > western Pacific 
region > Africa) remained stable compared with 1999 to 
2010. We isolated the majority of dengue virus geno-
types and epidemic lineages causing outbreaks and 
epidemics in Asia, America and Africa during the study 
period. Travellers acted as sentinels for four unusual 
dengue outbreaks (Madeira, 2012–13; Luanda, 2013; 
Dar es Salaam, 2014; Tokyo, 2014). We were able to 
characterise dengue viruses imported from regions 
where currently no virological surveillance data are 
available. Up to 36% of travellers infected with dengue 
while travelling returned during the acute phase of the 
infection (up to 7 days after symptom onset) or became 
symptomatic after returning to Europe, and 58% of the 
patients with acute dengue infection were viraemic 
when seeking medical care. Epidemiological and viro-
logical data from dengue-infected international travel-
lers can add an important layer to global surveillance 
efforts. A considerable number of dengue-infected 
travellers are viraemic after arrival back home, which 
poses a risk for dengue introduction and autochtho-
nous transmission in European regions where suitable 
mosquito vectors are prevalent.
Background
Over the last decades, dengue has emerged as the 
most important arthropod-borne viral disease globally. 
Currently, almost half of the world’s population lives in 
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endemic regions, and it is estimated that ca 390 million 
infections occur annually, of which 96 million cases 
manifest clinically. In the absence of a vaccine and due 
to the limited efficacy of vector control strategies, den-
gue has seen a 30-fold increase in disease burden over 
the last half century, primarily in tropical and subtropi-
cal regions of South-east Asia, the Pacific region and 
the Americas [1]. With increasing international tourism, 
dengue has also emerged as an important cause of 
fever in travellers returning from endemic regions, and 
the frequency of dengue importation to non-endemic 
regions such as Europe continues to increase [2,3]. This 
trend is paralleled by the introduction, or presence and 
rapid expansion, of potential mosquito vectors such 
as Aedes (Stegomyia) albopictus, which is currently 
present in at least 15 European countries [4]. While A. 
albopictus is present in the Mediterranean region, A. 
aegypti, the primary vector of dengue in most endemic 
regions of the world, is found on Madeira (where A. 
albopictus is absent) and in the Black Sea region of 
Russia’s Southern Federal District (Sochi region) and 
the neighbouring Abkhazia region of Georgia (where A. 
albopictus is also absent) [5].
Therefore, dengue does not only pose a risk to the 
health of the individual traveller but is also a public 
health problem as travellers contribute to the spread 
of the disease [6]. The potential threat from dengue 
importation to non-endemic, but vector-infested, 
regions has been highlighted in the recent years 
by cases of autochthonous dengue transmission in 
southern Europe [7-9] and a major outbreak with more 
than 2,000 autochthonous dengue cases in Madeira, 
Portugal from 2012 to 2013 [10]. Although a great deal 
of effort is made to prevent the spread of dengue 
viruses via infected mosquitoes by implementing mos-
quito abatement programmes at international airports 
and spraying adulticides in passenger cabins of arriv-
ing aircraft, mosquitoes as agents of spread are prob-
ably overrated and viraemic travellers are a more likely 
source of importation of dengue viruses [6]. Therefore, 
when assessing the risk of introducing dengue to 
Figure 1
Geographical distribution of imported dengue cases, by WHO region, 2012–14 (n = 242)
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non-endemic regions like Europe, the key focus of sur-
veillance is, besides evaluation of the local prevalence 
and distribution of potential mosquito vector species, 
to evaluate the extent of imported dengue via travel-
lers. This task was covered by the European Network 
for Tropical Medicine and Travel Health (TropNet) in the 
past and is currently covered by the European Travel 
Medicine Network (EuroTravNet).
In addition, sentinel surveillance of travellers repre-
sents an additional important layer in the currently still 
fragmentary global surveillance situation. Especially 
travellers returning from regions where surveillance 
capacities are limited can uncover outbreaks that 
would otherwise go unnoticed. The detection of dengue 
fever in 10 travellers returning from Luanda, Angola to 
five countries on four continents in 2013 highlights this 
aspect [11]. Genetic characterisation of dengue virus 
strains collected from different geographical locations 
over time via returning travellers offers the opportunity 
to understand the global distribution and evolution of 
dengue sero- and genotypes and may allow us to iden-
tify and trace virus strains with epidemic potential that 
pose an increased risk of introduction to non-endemic 
regions like Europe [12].
The aims of this study were to report the phylogeny 
and genetic characteristics of dengue viruses imported 
to Europe by returning travellers and to describe the 
epidemiological trends of dengue infections imported 
to Europe by returning travellers.
Methods
Study objectives, patient recruitment and 
sample collection
The presented data were collected within the framework 
of the DengueTools research initiative (funded by the 7th 
Framework Programme for Research and Technological 
Development of the European Commission) as part of 
a study conducted in research area 3, ‘Risk of dengue 
spreading to uninfected regions’ work package 6, ‘sen-
tinel surveillance of imported dengue in returning trav-
ellers: trends and virus evolution’ [13]. The study was 
conducted as a prospective observational multi-cen-
tre study by major TropNet centres, enrolling patients 
with acute dengue infections between September 2011 
and December 2014. The participating TropNet sites 
were: Antwerp (Belgium), Munich (Germany), Berlin 
(Germany), Hamburg (Germany), Negrar (Italy), Turin 
(Italy), Brescia (Italy), Leiden (the Netherlands), Madrid 
(Spain), Barcelona (Spain), Basel (Switzerland) and 
Lausanne (Switzerland). The study was approved by 
the responsible ethics committees at all participating 
study sites.
Between September 2011 and December 2014, all 
European residents (all age groups) returning from 
dengue-endemic regions and presenting with an acute 
dengue infection (confirmed by PCR, NS1 antigen detec-
tion or positive IgM serology at the participating study 
sites) no later than 7 days after onset of fever, were 
eligible for study inclusion. The cut-off at 7 days of ill-
ness was chosen because virus isolation after this time 
point becomes unlikely due to declining viraemia. After 
signing the informed consent form, the participants 
completed a questionnaire on demographic data, travel 
history, clinical and paraclinical data and blood serum 
was obtained and stored at −80 °C for latter shipment 
on dry ice to the National Centre of Microbiology at the 
Instituto de Salud Carlos III (ISCIII) in Madrid, Spain, 
where all samples (tested positive at the participating 
study sites) were processed for virus sequencing and 
virus isolation.
Virus isolation, sequencing and phylogenetic 
analysis
Sero- and genotyping was performed by RT-PCR tar-
geting the junction between the envelope (E) and 
non-structural 1 (NS1) protein genes with subsequent 
sequencing of 400–500 bp of the E/NS1 region for each 
serotype as described previously [14]. The sequences 
were edited and analysed in Mega 6 software [15] using 
maximum likelihood or neighbour-joining methods. All 
samples were subjected to virus isolation in C6/36 A. 
(S.) albopictus mosquito cells.
Figure 2
Geographical pattern of imported dengue cases, by WHO 
region, 2012–14 (n = 242)
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Results
Demographic data of enrolled cases
Between September 2011 and December 2014, a total 
of 673 laboratory-confirmed imported dengue cases 
were seen at the participating study sites, of whom 
244 (36%) presented during the acute phase of the 
infection (≤ 7 days after onset of symptoms). Of the 
244 patients, 242 consented to participate in the study 
and were enrolled. Table 1 shows the number of cases 
enrolled per country and their travel profile. Some 128 
(53%) of enrolled patients were male (median age: 41 
years; range: 17–73 years) and 114 (47%) were female 
(median age: 32 years; range: 17–73 years).
Geographical origin of imported dengue cases
Figure 1 shows the geographical background of the 
imported dengue cases by World Health Organization 
(WHO) region: 125 cases (52%) were imported from 
the South-east Asian region, 63 cases (26%) from 
the Americas, 21 cases (8%) from the Western Pacific 
region, 14 cases (6%) from the African region, two 
cases (0.8%) from Madeira (Portugal) and 17 cases 
(7%) had visited two different WHO regions in the 
incubation period. Of the 17 cases who had visited 
two WHO regions, 14 travellers had visited countries 
of the neighbouring WHO regions South-east Asia and 
Western Pacific and three cases had visited two non-
neighbouring WHO regions in the incubation period. 
Virus isolation and sequencing was successful in two 
of the three cases who had visited two non-neighbour-
ing WHO regions in the incubation period. 
Pattern of imported dengue cases during the 
study period
Because ethical clearance was obtained by the study 
sites at different time points, the cases collected in 
2011 (n = 21) were not homogeneously enrolled into the 
study and therefore excluded from the trend analysis. 
In 2012, 2013 and 2014, all participating study sites 
recruited patients. Figure 2 depicts the overall importa-
tion pattern of acute dengue fever from January 2012 to 
December 2014. No seasonal importation pattern was 
observed from any endemic region (data not shown).
Proportion of travellers presenting with acute/
viraemic dengue infection
To assess the overall risk of dengue importation by 
potentially infectious/viraemic travellers (who may 
introduce the virus to regions of Europe where suit-
able mosquito vectors are present) we assessed the 
proportion of acutely ill/viraemic travellers among all 
imported dengue cases seen at the participating study 
sites. Of 673 imported dengue cases seen during the 
study period, 244 (36%) presented during the acute 
phase of the infection (≤ 7 days after onset of symp-
toms). The remaining 64% of patients presented later 
than 7 days after onset of illness (mainly for follow-up 
or confirmation of the diagnosis) but we have no fur-
ther details on these patients as our aim was to include 
acutely ill, potentially viraemic travellers. Among the 
242 study participants presenting with acute den-
gue (symptoms ≤ 7 days), 87 (36%) already developed 
symptoms while travelling and 155 (64%) became 
symptomatic after returning home. Figure 3 shows the 
delay between onset of symptoms and returning home. 
Of the 242 acute dengue cases, 160 (66%) were posi-
tive by PCR and virus isolation followed by sero- and 
genotyping was successful in 141 (58%) cases.
Virus isolation, sequencing and phylogenetic 
analysis
Of the 141 virus isolates that could be typed, DENV-1 
was identified in 46% (n = 65), DENV-2 in 26% (n = 37), 
DENV-3 in 16% (n = 23) and DENV-4 in 11% (n = 16) of 
cases (Tables 2 and 3). All four dengue serotypes were 
imported by travellers, irrespective of which region 
they had visited (Figure 4). The two dengue infections 
acquired within the European region were diagnosed 
in travellers returning from Madeira during the local 
dengue outbreak in 2012–13 and were due to DENV-1 
(Figure 4).
Overall, DENV-1 (n = 65) was the serotype most fre-
quently detected in the study population. All isolated 
DENV-1 strains belonged to two of the five genotypes 
previously described [16-18]: genotype I (Asian) and 
genotype V (America-Africa). The most notable find-
ings were:
Genotype I (Asian): All genotype I (Asian) virus strains 
(n = 42) were isolated from travellers returning from 
Asia. One virus was isolated from a traveller returning 
from Japan in September 2014; the case was linked to 
Figure 3
Time between onset of symptoms and returning back 
home in returning travellers developing dengue fever, 
2012–14 (data available from 143 travellers)
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a local outbreak with ca. 160 reported autochthonous 
cases affecting Tokyo from August to September 2014 
[19].
Genotype V (America-Africa): As reported previously 
[14], genotype V (America-Africa) strains (n = 23) show 
a vast geographical distribution and we isolated virus 
strains from travellers returning from the Americas, 
Africa and Asia. Three cases were notable: two virus 
strains from travellers returning from Madeira during 
the dengue epidemic in 2012 and 2013 and one virus 
strain from a traveller returning from Angola during the 
dengue outbreak in 2013 [20].
The isolated DENV-2 strains (n = 37) grouped into three 
different genotypes that currently are of high epide-
miological interest: genotypes America-Asia (n = 9), 
Cosmopolitan (n = 23) and Asian I (n = 5).
Genotype America-Asia: All strains were isolated from 
travellers returning from the Americas.
Genotype Cosmopolitan: We isolated two virus strains 
from travellers returning from Tanzania in 2014 at the 
time of an ongoing dengue outbreak in Dar es Salaam 
and neighbouring regions (personal communica-
tion: Boillat N, Sep 2015). The isolated virus strains 
clustered in a lineage different from the strains intro-
duced to Africa in the early 1980s.
Four different genotypes of DENV-3 (n = 23) were 
detected during the study period: genotypes I (n = 7), 
II (n = 5), III (n = 8) and IV (n = 23), suggesting a broad 
expansion and diversity of circulating DENV-3 strains. 
The most notable findings were the isolation of two 
genotype III strains from travellers returning from Cuba 
in 2013 and 2014, suggesting epidemic circulation of 
these strains, and the isolation of a genotype III strain 
from a traveller returning from Burkina Faso in 2013, 
a region for which data on dengue endemicity are not 
available.
DENV-4 strains were the least frequently isolated virus 
strains in our study. All DENV-4 strains imported from 
the Americas (n = 16) belonged to genotype II, the main 
genotype circulating in the region since its introduction 
in 1982 [14]. All detected strains of DENV-4 from Asia 
(n = 16) were genotypes I (n = 7) and II (n = 9). Most 
notably, we isolated a genotype II strain from a travel-
ler returning from Angola which showed 98% homology 
to strains currently circulating in Brazil, confirming pre-
vious data suggesting that the 2013 DENV-4 outbreak 
Figure 4
Distribution of imported dengue virus serotypes, by WHO region, 2012–14 (n = 141)
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in Luanda was caused by a virus strain introduced from 
Brazil [21].
Discussion
The observed geographical pattern of the origin of 
imported dengue by international travellers was in line 
with previous reports from TropNet (1999–2001: South-
east Asian/Western Pacific region: 53.4%, American 
region 36.5%, African region: 10.3%) [22] and data from 
the GeoSentinel network (2000–10: South-east Asian/
western Pacific region: 67%, American region: 28%; 
African region: 5%) [23].
The peak of imported dengue cases observed in 2013, 
compared with 2012 and 2014, was mainly attributable 
to the increase in cases imported from the Americas 
and South-east Asia and is in line with the isochronal 
epidemiological trend observed in these regions: The 
Pan American Health Organisation (PAHO) reported 
1,120,902 cases in 2012, 2,386,836 cases in 2013 and 
1,176,529 cases in 2014 which occurred in the American 
region [24]. Although neither the WHO figures for the 
South-east Asian region nor the official figures from 
Thailand (which accounts for the majority of dengue 
cases imported from the South-east Asian region 
to Europe) were traceable, accessible online media 
sources reported that in 2013, Thailand experienced its 
worst dengue epidemic in more than two decades [25], 
followed by a significant decline in cases in 2014 [26]. 
From 2012 to 2014, the overall geographical pattern 
of the origin of imported dengue to Europe remained 
unchanged and the importation pattern over the years 
appears to match the epidemiological situation in 
endemic regions. However, it should be kept in mind 
that the absolute numbers of dengue infections in trav-
ellers returning from different destinations primarily 
reflect the popularity of travel destinations and cannot 
provide incidence rates or an assessment of infection 
risk, as data on the exact number of travellers to the 
different regions (denominator) are not available.
Among the imported dengue cases, three travellers 
(1.2%) had visited two non-neighbouring WHO regions 
during the possible incubation period, highlighting the 
potential role of international travellers in transconti-
nental spread of DENV strains. This is corroborated by 
the DENV strains isolated from two of these three trav-
ellers: The virus isolated from a patient who travelled 
from Indonesia to Peru points to Indonesia as the most 
likely place of acquisition and the identified genotype 
has not yet been known to circulate in Peru. The virus 
isolate from the patient who travelled from Malaysia to 
Brazil points to Brazil as the most likely place of acqui-
sition. (Note: the detailed phylogenetic analysis of all 
DENV isolated within the framework of this study is 
envisaged but currently pending). 
When looking at the number of dengue cases enrolled 
into the study over time, no seasonal pattern of impor-
tation was detected. However, the number of enrolled 
cases may have been insufficient to see a seasonal 
trend. The European Centre for Disease Prevention and 
Control (ECDC) reports a seasonal trend of imported 
dengue cases in Europe, increasing during the sum-
mer and autumn months (June–October) and peaking 
in August [27]. This may be explained by the European 
summer holiday season with the corresponding 
increase of international travel during this time of the 
year as well as the epidemiological peak of dengue 
cases at the major holiday destination South-east Asia 
from June to September [28]. Mathematical modelling 
of the likelihood of dengue importation to Europe (tak-
ing into account dengue seasonality in the countries 
from which dengue could be imported, the number 
of reported dengue cases imported into Europe and 
the volume of airline travellers arriving from dengue-
affected areas internationally) concluded that the risk 
of dengue importation is greatest in August, September 
and October [29]. Entomological monitoring in the 
Mediterranean region indicated that the development 
period for A. albopictus starts in April and closes in 
October/November with activity peaks from June/July 
to September [30,31]. The peak activity of A. albopictus 
populations in the south of Europe thus coincides with 
the seasonal peak of imported dengue cases in Europe 
which increases the risk of autochthonous transmis-
sion [29,32]. Case reports of autochthonously acquired 
dengue in Croatia and the south of France in August 
and September in the past years support this predic-
tion [7-9]. We found that more than a third of travellers 
who are infected with dengue in endemic regions either 
return to Europe during the acute phase of the infection 
or become symptomatic after returning back home. 
More than half of the patients presenting with acute 
dengue infection were viraemic when seeking medical 
care. If we equate viraemia with risk of transmission, 
we can conclude that at least 58% (141/242) of dengue 
patients presenting during the acute phase of infection 
Table 1
European imported dengue cases enrolled in the study, by 
country and travel profile, 2012–14 (n = 242)
Number of cases %
Enrolled cases by country
Belgium 25 10.3
Germany 73 30.2
Italy 37 15.3
The Netherlands 13 5.4
Spain 74 30.6
Switzerland 20 8.3
Travel profile of cases
Individual tourists 132 54.5
Package tourists 50 20.7
Visiting friends and relatives 29 12.0
Business travellers 23 9.5
European overseas residents/
expatriates 8 3.3
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may pose a potential risk to initiate autochthonous 
transmission in vector-infested regions of Europe. 
Travellers returning to regions where no A. albopictus 
is prevalent will, even if viraemic, not pose any rel-
evant risk for authochtonous transmission. The used 
cut-off of 7 days for study enrolment was a pragmatic 
decision and does not exclude that some patients may 
be viraemic beyond that period. Thus, the observed 
proportion of viraemic cases should be seen as a mini-
mum. Of note, almost half of the included 242 cases 
were enrolled by TropNet sites in Spain (Barcelona) and 
Italy (Brescia, Torino and Verona) where A. albopictus 
is prevalent.
Worldwide surveillance of circulating DENV strains is 
crucial for the understanding of transmission patterns 
and for tracking the emergence and spread of virus 
strains (especially those with high epidemic potential) 
around the world. However, currently global surveil-
lance data remain fragmentary. This is especially true 
for resource-poor regions where no or only limited local 
surveillance data are available. Sentinel surveillance of 
international travellers returning with DENV infections 
from such regions has been suggested as a valuable 
tool for filling these current data gaps [6,14] and the 
phylogenetic analysis of our isolated DENV strains 
confirms this: We detected all four DENV serotypes in 
travellers returning from Asia, the Americas and Africa 
and identified the main genotypes and epidemic lin-
eages causing outbreaks and epidemics during the 
study period (the DENV-1 genotypes America-Africa 
and Asian, the DENV-2 genotypes Cosmopolitan and 
Asian I and the DENV-3 genotype III). We also picked 
up changes in DENV strain circulation, e.g. we isolated 
a genotype I Asia strain in a traveller returning from 
Indonesia in 2013 at the same time as local reports 
describing a shift from the predominantly circulat-
ing cosmopolitan genotype strains to Asian genotype 
strains [33].
For regions where currently only scarce or no regional 
surveillance data are available, virus characterisation 
revealed several interesting findings: 
Firstly, although 1,430 (clinical) dengue cases were 
officially reported in Cuba in 2013 and 2,522 in 2014, 
no dengue serotypes have been reported to PAHO/
WHO for those years [24]. In our study, more than 10 
years later, we detected circulation of dengue serotype 
3 (genotype III) in Cuba in 2013 and 2014. According 
to PAHO, other Hispanic Caribbean countries did not 
report this serotype in those years. The last detection 
of dengue 3 (genotype III) in Cuba was during a big epi-
demic in 2001 and 2002 [14,34].
Secondly, we identified dengue virus circulating in 
countries in Africa that have so far rarely reported 
dengue. We isolated a genotype III DENV-3 strain from 
a traveller returning from Togo and Burkina Faso, a 
region where, besides one recent case report of a gen-
otype III DENV-3 infection in a returning German travel-
ler [35], circulation of dengue had been unknown. We 
also identified a dengue virus strain imported during 
the dengue outbreak in Angola in 2013. In a previ-
ous report, the outbreak was thought to be due to an 
endemic virus strain that had been circulating in West 
Africa for many years [20]. However, our analysis points 
towards an importation of a dengue virus from Brazil, 
consistent with a report by researchers from Portugal 
[21]. Furthermore, we isolated DENV from travellers 
returning from Tanzania during the dengue outbreak 
affecting Dar es Salaam and neighbouring regions in 
2014 [36]. The isolated virus strains clustered in a lin-
eage different from the strains introduced in Africa in 
the early 1980s, suggesting recent introduction from 
Asia.
Thirdly, our sentinel surveillance picked up a dengue 
outbreak in Europe: the 2012/13 outbreak in Madeira, 
Portugal [10].
Finally, the genotype I (Asian) DENV-1 isolate we 
isolated from a traveller returning from Japan in 
September 2014 was linked to a local outbreak with 
ca. 160 reported autochthonous cases affecting Tokyo 
in August and September 2014 [19]. The only previous 
autochthonous transmission of dengue in Japan was 
reported in 2013, when a DENV-2 strain was isolated in 
a returning German traveller [37], although no concur-
rent local cases were reported at that time and autoch-
thonous transmission of dengue had not been reported 
in Japan for 70 years [19]. Despite Japan’s temperate 
Table 2
Study participants with imported dengue virus infection (n = 673) and PCR-positive cases wit available virus sequence 
(n = 141), 2012–14 
Recruitment of study participants and processing of samples Number of cases
All dengue cases seen at the participating study sites during the study period 673
Laboratory-confirmed acute dengue cases presenting within ≤ 7 days after onset of symptoms to one of the study sites 
( = enrolled patients according to inclusion criteria) 242
PCR-positive acute dengue cases 160
Acute dengue cases where sequencing and virus isolation was successful 141
8 www.eurosurveillance.org
climate, increasing travel between Japan and dengue-
endemic areas, combined with more suitable climate 
and environmental drivers for dengue transmission, 
have made such an outbreak possible [38]. 
In conclusion, our data demonstrate that epidemiologi-
cal and virological data obtained from dengue-infected 
international travellers can add an important layer to 
global dengue surveillance efforts.
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